Gynecology Ultrasound Systems

Stryker Corporation is a global medical technology company headquartered in Portage, Michigan, serving hospitals, surgical centers, and healthcare providers worldwide. The company manufactures and distributes a comprehensive portfolio of medical devices, surgical equipment, implants, and visualization systems across multiple specialties including orthopedics, neurosurgery, spine, trauma, cardiovascular, endoscopy, acute care, and emergency medicine. Key product categories include joint replacement implants (hips, knees) with Mako Robotic-Arm Assisted Technology, neurosurgical and spine instruments with 3D-printed technologies, minimally invasive surgical systems (laparoscopy, arthroscopy, endoscopy), emergency care equipment, communications systems for patient environments, interventional spine products (vertebroplasty, radiofrequency ablation), craniomaxillofacial solutions, sports medicine implants, and neurovascular stroke care devices. Stryker operates manufacturing facilities in multiple countries including Canada, China, and the US. The company maintains a strong commitment to sustainability through device reprocessing and remanufacturing services for single-use medical devices. With regional headquarters and distribution centers across the Americas, Europe, Asia-Pacific, and Middle East & Africa, Stryker provides integrated sales, service, and technical support. The company is regulated by the FDA and maintains global certifications for medical device manufacturing and quality management systems.

NIRAMAI Health Analytix is an AI-powered medical device company specializing in thermal imaging-based breast cancer screening. Founded in 2016 and headquartered in Bangalore, India, the company develops non-invasive, radiation-free diagnostic solutions for early breast cancer detection. The core technology, Thermalytix, is a computer-aided diagnostic engine combining high-resolution thermal sensing with cloud-hosted machine learning analytics to analyze thermal images and detect breast abnormalities. The platform is clinically validated, backed by 39 patents and 55+ peer-reviewed publications, and has screened 300,000+ women across 200+ hospitals in 22+ countries. NIRAMAI's thermal imaging approach offers significant advantages: it is painless, contactless, privacy-preserving, and operates at 10-20% of the cost of traditional screening methods. The technology is accessible across age groups (18-80+) and is particularly suited for primary care clinics, remote communities, and outreach programs. NIRAMAI SMILE-100, the company's flagship system, received US FDA clearance and CE marking for European markets. The company has received numerous international awards including World Bank Global Women Health Award, National Startup Award, and recognition as a top 100 AI startup globally.

Nexpring Health is a global MedTech company focused on Assisted Reproductive Technology (ART), formed in 2025 through the combination of Hamilton Thorne, Cook Medical's Reproductive Health business, FUJIFILM Irvine Scientific's Medical Media Business, and several other specialized fertility providers. Headquartered in Beverly, Massachusetts, the company brings together over 40 years of cumulative industry expertise to serve embryologists, clinicians, and fertility clinics worldwide. Nexpring Health offers a comprehensive end-to-end ART portfolio encompassing innovative devices, culture media, consumables, and support services designed for every stage of the IVF cycle—from pre-IVF diagnosis and sperm preparation through ovum pickup, fertilization, embryo development, embryo transfer, and cryopreservation. Key products include the Guardia™ Access Embryo Transfer Catheter family, Gynemed Specialty Media formulations, CASA systems for semen analysis, embryo culture media, cryopreservation equipment (Kryo series), incubators, aspiration needles, micromanipulation instruments, and laboratory monitoring systems. The company emphasizes streamlined workflows, product quality, and direct collaboration with ART professionals to address challenges in fertility clinic operations and improve patient outcomes.

Cycle Clarity is a healthcare technology company specializing in AI-driven clinical decision support for reproductive medicine. The company's flagship product, MyCycleClarity, combines Follicle Clarity—an FDA-cleared neural network—with cloud-based analytics to standardize and accelerate ovarian follicle measurements during fertility treatment monitoring. The platform integrates with electronic medical records to provide real-time follicle detection, measurement accuracy, and predictive analytics for optimal oocyte retrieval timing. Key benefits include reduced ultrasound scan times (from 15–20 minutes to 2–3 minutes per patient), standardized measurements across providers, improved clinical workflow efficiency, decreased patient discomfort, and better resource allocation in fertility clinics. HIPAA and SOC2 compliant. Serves leading fertility centers nationally.

Bexa, Inc. is a medical technology company specializing in early breast cancer detection through portable, radiation-free elastography devices. The Bexa system uses pressure elastography technology to deliver accurate, painless breast exams without radiation exposure. Designed for rapid on-site deployment by trained female examiners, the device provides immediate results and performs equally well across all breast densities, including dense breast tissue where traditional mammography shows reduced sensitivity. The company prioritizes health equity and accessibility, targeting underserved populations including women in low-income communities, rural areas, and marginalized demographics with higher breast cancer mortality rates. Bexa offers comprehensive service integration including clinical validation, examiner training, and healthcare provider partnerships. With over 200,000 exams performed globally since 1997, the company combines clinical efficacy with affordable pricing models to democratize early detection and reduce cancer-related health disparities.

Femasys Inc. is a woman-founded and led biomedical company dedicated to enhancing women's healthcare through innovative, minimally invasive, non-surgical technologies. The company focuses on addressing significant needs in infertility, contraception, and cancer diagnostics. With a mission to provide safe and accessible solutions, Femasys aims to improve patient care and health standards globally, supported by a robust portfolio of approximately 200 patents. The company develops a range of therapeutic and diagnostic products using a proprietary non-surgical delivery platform. Key offerings include FemaSeed, an intratubal insemination device; FemVue, an ultrasound-based diagnostic tool; FemBloc, a candidate for non-surgical birth control; and FemCerv, a tissue sampler for cervical cancer diagnosis. Femasys emphasizes safety and efficiency in its in-office approaches, with a commitment to empowering women throughout their reproductive journeys. The company is publicly traded on NASDAQ under the ticker FEMY.

MedGyn Products, Inc. is a leading B2B medical device manufacturer and distributor specializing in obstetric and gynecological equipment, instruments, and disposables for OB/GYN professionals worldwide. Based in Westmont, Illinois, with over 50 years of experience, the company offers a comprehensive product portfolio addressing family planning, general gynecology, gynecology/oncology, infertility, obstetrics, and urogynecology. Key product lines include digital video colposcopes (AL-106 HD), thermal ablation systems (MTA-100) for cervical cancer therapy, cryotherapy systems, pessaries for pelvic organ prolapse management, endometrial sampling devices (Endosampler™), and disposable colposcopy kits. MedGyn manufactures surgical instruments, electrosurgical generators, and endocervical sampling tools. The company maintains a strong commitment to cervical cancer prevention, maternal health innovation, and women's health equity, with extensive international distribution and recognition for excellence in product design and clinical performance.

Vathin Medical Instrument Co., Ltd. (also operating as Huaxin Medical) is a leading global manufacturer of disposable electronic endoscopes and minimally invasive surgical instruments. Founded in 2018 and headquartered in Xiangtan, Hunan Province, the company employs over 300 personnel with R&D and sales centers in Berlin and Shanghai. Vathin specializes in innovative disposable endoscope technologies across pulmonology, urology, otolaryngology, and gastroenterology, featuring proprietary riveted snake-bone designs enabling superior articulation (up to 210° bending angles) and precision positioning. The company operates an automated manufacturing facility producing 400,000 units annually with ISO certifications and over 200 patent applications. Vathin products are FDA and CE approved, distributed across 160+ countries, and marketed through strategic partnerships including Olympus. Product portfolio encompasses disposable bronchoscopes, cystoscopes, ureteroscopes, rhinolaryngoscopes, and complementary minimally invasive surgical instruments including laparoscopic staplers and ultrasonic energy devices. The company addresses clinical demand for infection-free, cost-effective alternatives to reusable instruments while supporting graded diagnosis and treatment protocols.

iSono Health develops the ATUSA system, a fully automated, portable 3D breast ultrasound scanner with integrated AI-driven software for point-of-care imaging. The ATUSA system enables rapid whole-breast scanning in approximately two minutes per breast without requiring a trained ultrasound technologist, making expert-level breast imaging accessible in physician offices and women's health clinics. The device features a wearable accessory, automated scan acquisition, and a dual software architecture: a Windows-based desktop/tablet application for real-time 2D visualization, measurement, and review, plus a secure cloud-based web application enabling remote access and advanced 3D visualization with multi-planar reconstruction (radial, coronal, sagittal, transverse views). The system performs standardized, reproducible whole-breast image acquisition with consistent accuracy comparable to manual ultrasound specialist examination. ATUSA has received FDA 510(k) clearance. The platform targets longitudinal, personalized risk-based monitoring for high-risk individuals, improving access to frequent breast imaging surveillance. AI features are currently in the research phase. The company emphasizes operator-agnostic design, fast acquisition, and seamless cloud-based remote monitoring capabilities for patient tracking and remote care workflows.

UE LifeSciences Inc. is a medical device innovator focused on accessible, hand-held diagnostic solutions for early cancer detection in resource-limited and low-income settings. The company develops non-invasive, radiation-free, pain-free screening devices operable by community health workers with minimal training and offline capability, enabling instant results with validated high efficacy. Their product portfolio addresses breast, cervical, and oral cancer screening—the leading cancer burdens in underserved populations globally. iBreastExam is an extensively validated handheld breast lump detection device; cervAIcal is a mobile colposcope for cervical cancer assessment; OrCA addresses oral cancer screening. RaKSA is a multi-cancer screening navigation initiative integrating breast, cervical, and oral examination into single-visit protocols for large-scale implementation. The company has supplied over 2 million breast exams, detected 500+ cancers, and operates in 10 markets across USA, India, Malaysia, Colombia, and Thailand. UE LifeSciences partners with HLL Lifecare (India), major imaging-diagnostics firms, and regional pharma and diagnostics distributors. The company has raised $8.5M in capital, secured $1.7M+ in grants, and earned 15+ awards. Featured in The New York Times, BBC News, Forbes, and TED Talks, UE LifeSciences targets primary and secondary care providers, government health programs, NGOs, and private healthcare networks seeking equitable early detection infrastructure.

S.H. Medical Corp. is a Miami-based medical equipment distributor specializing in new and reconditioned surgical and diagnostic instruments. The company offers comprehensive product lines across minimally invasive surgery (laparoscopy, arthroscopy), endoscopic systems (flexible endoscopes, video systems), orthopedic and trauma equipment, ENT instrumentation, and urology/gynecology accessories. The product portfolio includes high-end equipment from leading manufacturers such as Arthrex, STAHL, Storz, and Valley Lab, ranging from shavers and electrosurgical devices to fiber optic light cables and surgical staplers. S.H. Medical serves hospitals, surgical centers, and veterinary facilities, offering both new inventory and professionally reconditioned units to meet diverse facility needs and budget requirements.

PARICO Medical LLC manufactures professional-grade treatment and diagnostic tables engineered for clinics, physiotherapy centers, sports medicine practices, and diagnostic imaging environments. The company specializes in electric hi-lo treatment tables (iPRO and BASE series) with multi-angle adjustability, power imaging tables for ultrasound and interventional procedures, and height-adjustable clinical stools. All equipment features TIMOTION premium motors, ISO 13485 manufacturing certification, CE and FDA approval, and includes 5-year warranties. PARICO emphasizes cost-effective pricing, US-based distribution, responsive after-sales support, and parts availability. The company serves clinics seeking reliable, ergonomic medical furniture without premium pricing.

EdanUSA is a San Diego-based distributor and service center for FDA-approved diagnostic medical equipment, established in 2009 to provide U.S. local support and inventory. The company stocks over $1 million in diagnostic equipment and spare parts, serving over 100 resellers across the United States. EdanUSA specializes in high-quality, cost-effective diagnostic devices including patient monitors, ECG/EKG machines, ultrasound systems, fetal monitors, Holter monitors, pulse oximeters, colposcopes, Dopplers, and vital sign monitoring equipment. All products are backed by a three-year manufacturer warranty with on-site customer service and factory-trained engineers guaranteeing 24-48 hour service turnaround. The company offers pricing 30-40% below major U.S. competitors while maintaining comprehensive support through a dedicated service center, learning resources, and EMR connectivity assistance.

Sonio is a cloud-based AI-powered ultrasound reporting software platform specializing in OB-GYN and prenatal care. The platform integrates with ultrasound machines from all manufacturers to deliver FDA-cleared and CE-marked AI diagnostics, quality control, and automated reporting workflows. Key capabilities include Sonio Detect (AI-assisted anomaly detection), automated image management with intelligent view sorting, real-time quality control verification, visual checklists for exam completeness, integrated practice analytics, and seamless connectivity to EHRs, PACS, billing systems, and external providers via HL7/FHIR/eFAX. The platform enables sonographers and OB-GYNs to standardize reporting, improve diagnostic accuracy, reduce manual data entry, and enhance prenatal care access globally. Sonio operates on secure cloud or on-premise infrastructure with SOC2 Type II, HIPAA, ISO 13485, and GDPR compliance.

Halo Medical Technologies designs and manufactures high-resolution 2D/3D multicompartment ultrasound systems specialized in anorectal and pelvic floor imaging. Founded by pelvic floor experts, the company delivers the Catalyst Ultrasound Systems line, available in both compact and conventional configurations to suit space-constrained and high-volume clinical environments. Core imaging modalities include endoanal, transrectal, endovaginal, and transperineal approaches. The systems feature innovative software-guided workflows, 60-second video capture and replay capability, still-image freeze-frame functionality, and auto-generated EMR-ready reports with auto-populated measurements and interpretations. Clinical indications addressed include defecation disorders, pelvic floor dysfunction, fistulas, benign and malignant disease, prolapse, sling detection and management, and dynamic ultrasound assessment. Halo also manufactures specialized ultrasound probes designed for pelvic floor applications. The company provides complementary clinical resources including the Atlas of Images—a comprehensive library of over 150 pages of pelvic floor ultrasound imagery, diagrams, videos, and educational content available online and in PDF form. Support materials include instructions for use (IFU), CPT coding guidance, patient questionnaires, and technical documentation. Target markets include urogynecologists, colorectal surgeons, gastroenterologists, and female urologists. The company emphasizes affordability and clinical utility in its product design philosophy.

Liberty Medical Inc manufactures specialized medical devices and accessories for brachytherapy and cancer treatment. The company produces a range of products including FlexiNeedles, implant needles, fiducial markers, prostate templates, intrauterine tandems, OB/GYN templates, radiopaque buttons, and catheters. These devices are designed to support internal radiation therapy (brachytherapy) procedures, which involve surgically placing radioactive seeds or capsules directly in or near cancerous tumors. Liberty Medical's product portfolio serves oncology and radiation therapy departments in hospitals and cancer treatment centers. The company maintains a detailed product catalog and operates order fulfillment services. While specific regulatory certifications are not detailed on the primary website, brachytherapy accessories and medical devices in this category typically require FDA 510(k) clearance or equivalent regulatory pathways. The company serves as a supplier to radiation oncology departments requiring precision accessories for cancer treatment applications.

Jiangsu Suyun Medical Materials Co., Ltd. is a professional manufacturer of single-use medical consumables founded in 1988 and headquartered in Lianyungang, Jiangsu Province, China. With nearly 40 years of production experience, the company operates four manufacturing plants across 300,000 square meters with 1,300 employees and serves over 2,000 customers globally. Suyun specializes in infusion sets, suction catheters, syringes, gynecological products (cytobrushes, spatulas, gynecological collectors), and examination instruments. The company provides OEM/ODM customization services with strong R&D capabilities, holding approximately 300 national patents. All products are certified by SFDA, GMP, US FDA, ISO 13485, CE, MDR, and FSC standards. Suyun maintains strict quality control including physical, biological, and chemical testing for every batch. The company emphasizes customer-centric service and timely delivery as core operational principles.

Surgical Direct is a surgical supplies and medical equipment distributor based in Orange City, Florida, serving healthcare professionals for over 20 years. The company maintains a curated inventory of over 17,000 surgical products and instruments across multiple specialties, including orthopedic, neurology, OB/GYN, ENT, and vascular. Core offerings include minimally invasive surgery instruments (laparoscopy, arthroscopy, cystoscopy, hysteroscopy), general and specialty surgical instruments (forceps, needle holders, retractors, scissors), and endoscopic equipment. Surgical Direct also operates an in-house instrument repair service (Instrument Surgeon) specializing in same-day repairs of flexible and rigid endoscopes, power equipment, and video systems from all major manufacturers. The company provides custom solutions including fiber light cable customization and laparoscopic instrument customization. Surgical Direct additionally serves veterinary markets and maintains a pre-owned equipment inventory. As a small business supplier (CAGE Code 3YWE4), the company emphasizes cost-effective solutions, rapid inventory access, and long-term customer relationships.

Vision Chips, Inc. develops specialized software solutions for OB/GYN practices, with a focus on ultrasound reporting and medical image management. Observer 7™ is a customizable ultrasound reporting interface designed to streamline report generation with minimal user effort, eliminating the need for transcription services. The platform integrates with their Image Archiving (PACS) system, providing comprehensive digital storage, retrieval, and management of ultrasound images and reports. The solution is tailored to meet the operational and compliance requirements of obstetric and gynecological imaging departments.

Calla Health Foundation is a medical device company focused on improving women's access to cervical cancer prevention and screening, particularly in low-resource settings. The organization develops portable, affordable diagnostic imaging technologies and AI-driven decision support systems designed to democratize gynecological examination and cancer prevention. Their product suite includes the Pocket Colposcope (a portable, low-cost video colposcope for cervical tissue examination), the Callascope (a speculum-free cervical imaging device enabling self-screening or provider-assisted insertion), and CARE (an AI algorithm for cervical pre-cancer risk assessment). The company's innovations enable midwives and community health workers to perform point-of-care screening and "see-and-treat" management paradigms without requiring traditional hospital infrastructure or specialized physician expertise. FDA-cleared and clinically validated in multiple low- and middle-income countries.

NEWPONG CO., Ltd. is a South Korean medical device manufacturer specializing in ultrasound-based aesthetic and gynecological medical equipment. The company develops and markets innovative devices utilizing high-frequency ultrasound energy (≥20 kHz) for therapeutic and surgical applications. Core product lines include SonoCare and SsonoCare for Women (therapeutic ultrasound devices for pain management and women's health), LSSA (ultrasonic surgical cutting instruments for tissue ablation), and Lincurve Pro (radiofrequency/ultrasonic tissue coagulation devices for aesthetic procedures). The company operates DEEP SONO LAB, a dedicated research and development facility focused on ultrasound technology advancement. NEWPONG maintains GMP certification and regulatory approvals for medical device manufacturing and has established a global distribution network across Asia, Europe, the Middle East, Africa, and Latin America.

Bio SB, Inc. is an FDA-registered and ISO 13485:2016 certified biotechnology manufacturer specializing in research, development, production, and distribution of antibodies and detection systems for molecular pathology. The company offers IVD validated monoclonal antibodies (rabbit and mouse), detection systems (ImmunoDetector, PolyDetector), and in situ hybridization technologies (FISH, CISH) for immunohistochemistry (IHC), immunocytochemistry (ICC), immunofluorescence (IF), and related diagnostic applications. Bio SB also manufactures automated staining equipment (TintoStainer Plus, TintoDetector) and tissue/cell line microarrays for cancer diagnostics, microbiology, immunology, and genetics research. The company serves biomedical laboratories, research institutions, and clinical settings globally, manufactured to FDA QSR 21 CFR Part 820 cGMP and CE IVD standards.

Modern Dental Laboratory USA is a full-service dental laboratory network operating eight centers across the United States (Atlanta, Boston, Michigan, California, Chicago, Savannah, Seattle, and Wilmington). The company specializes in precision dental restorations including implant restorations, crown and bridge, full-arch and All-on-X solutions, dentures, and custom oral appliances for sleep apnea treatment. Modern Dental serves dentist practices throughout the US with advanced digital workflows designed to reduce remakes and improve case acceptance. The company offers a comprehensive portfolio of restoration services featuring high-strength zirconia and esthetic materials, coupled with digital case planning support and technical consultation from experienced technicians. Product lines include ZiRneer zirconia restorations, MDN EVO Fusion systems, TrioClear clear aligners, digital support services (DSS), Ivotion milled dentures, and custom sleep appliances. Modern Dental emphasizes quality assurance, precision manufacturing, and consistent outcomes across its multi-center network. The company supports continuing education through World Dental Academy, offering online courses and webinars to help dental professionals stay current with digital dentistry technologies. Modern Dental positions itself as a trusted partner for practices seeking to reduce remakes while maintaining aesthetic and functional excellence in restorative cases.

QT Imaging Holdings, Inc. (QT Ultrasound LLC) is an FDA-cleared medical technology company specializing in automated breast imaging using quantitative transmission (QT) ultrasound technology. The flagship QTI Breast Acoustic CT™ Scanner delivers high-resolution 3D breast imaging without ionizing radiation or compression, utilizing low-frequency sound waves and AI-powered lesion classification. Designed for initial evaluation of asymptomatic high-risk women and those with dense breast tissue, the system combines advanced hardware with cloud-based image analytics and tissue biomarker analysis. The platform integrates with multimodality imaging workflows via the QTI Imaging-Olea Viewer and offers non-operator-dependent, safe alternatives to mammography, tomosynthesis, and MRI for breast cancer screening and diagnosis.